No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
SOUTH AFRICA —Pharmaceutical giant Johnson & Johnson (J&J), headquartered in the United States, is now under scrutiny in South Africa for purportedly imposing “excessive” pricing on a vital tuberculosis medication,…
Read More
SOUTH AFRICA — An analysis of South Africa’s COVID-19 vaccine contracts has shed light on pricing disparities and risk assumptions made by pharmaceutical companies. According to the Health Justice Initiative…
Read More
USA — Rapport Therapeutics, a cutting-edge neuromedicine startup backed by Johnson & Johnson, has announced the successful completion of a remarkable US$150 million series B funding round. Having launched earlier…
Read More
USA —Biosense Webster, a distinguished entity within Johnson & Johnson MedTech has unveiled its triumphant achievement of gaining U.S. Food and Drug Administration (FDA) approval for a zero-fluoroscopy workflow for…
Read More
USA — Johnson & Johnson has secured the coveted FDA approval for Akeega, a pioneering combination tablet poised to redefine the landscape of metastatic castration-resistant prostate cancer (mCRPC) treatment in…
Read More
INDIA – Johnson & Johnson Private Limited has selected Anuj Virmani as the new Managing Director for its medical device business in India. Anuj Virmani has been tapped as the…
Read More
USA —Johnson & Johnson, a prominent healthcare conglomerate, is brimming with optimism as it anticipates a year of strong growth, surpassing profit estimates. The resurgence of joint replacement surgeries and…
Read More
USA — As the battle intensifies over a new law aimed at lowering prescription drug prices, Johnson & Johnson’s pharmaceutical unit, Janssen Pharmaceuticals, has entered the fray, arguing that the…
Read More
SWITZERLAND —Efforts to expand access to Johnson & Johnson’s tuberculosis (TB) drug, Sirturo (bedaquiline), have faced criticism from Médecins Sans Frontières (MSF), also known as Doctors Without Borders. The deal…
Read More
SWITZERLAND —A recent licensing agreement between pharmaceutical giant Johnson & Johnson (J&J) and the Stop TB Partnership has sparked debate over its effectiveness in expanding access to life-saving tuberculosis (TB)…
Read More